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There are opposite views in the available literature: Whether physical exercise has a protective effect or not on the onset of
inflammatory bowel disease (IBD). Therefore, we investigated the effects of recreational physical exercise before the induction of
colitis. After 6 weeks of voluntary physical activity (running wheel), male Wistar rats were treated with TNBS (10mg). 72 hrs after
trinitrobenzene sulphonic acid (TNBS) challenge wemeasured colonic gene (TNF-𝛼, IL-1𝛽, CXCL1 and IL-10) and protein (TNF-𝛼)
expressions of various inflammatory mediators and enzyme activities of heme oxygenase (HO), nitric oxide synthase (NOS), and
myeloperoxidase (MPO) enzymes. Wheel running significantly increased the activities of HO, constitutive NOS (cNOS) isoform.
Furthermore, 6 weeks of running significantly decreased TNBS-induced inflammatorymarkers, including extent of lesions, severity
of mucosal damage, and gene expression of IL-1𝛽, CXCL1, and MPO activity, while IL-10 gene expression and cNOS activity were
increased. iNOS activity decreased and the activity of HO enzyme increased, but not significantly, compared to the sedentary
TNBS-treated group. In conclusion, recreational physical exercise can play an anti-inflammatory role by downregulating the gene
expression of proinflammatory mediators, inducing anti-inflammatory mediators, and modulating the activities of HO and NOS
enzymes in a rat model of colitis.
1. Introduction
Inflammatory bowel disease (IBD) is a chronic disease of
the gastrointestinal tract, which primarily comprises Crohn’s
disease (CD) and ulcerative colitis. Physical exercise can
be either harmful or beneficial for the gastrointestinal (GI)
tract depending on the training variables, such as exercise
intensity. For instance, it is believed that the reduced blood
flow to the gut during exercise can disturb the GI system [1].
Although there are similar studies suggesting the preventive
effect of active lifestyle on the onset of IBD, the available
literature is weak and contradictory [2, 3].
In the healthy gut interleukin-10 (IL-10) is the key
cytokine responsible for the anti-inflammatory environ-
ment, primarily through the suppression of proinflammatory
cytokines [4]. Once the anti- and proinflammatory balance
of the intestinal immune system is disturbed, the activated
and stimulated macrophages and T lymphocytes release
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proinflammatory mediators such as tumour necrosis factor-
𝛼 (TNF-𝛼), interleukin-1𝛽 (IL-1𝛽), and chemokine ligand
1 (CXCL1). The importance of anti- and proinflammatory
balance is reflected in the efficacy of anti-TNF-𝛼 therapy in
the treatment of IBD [5]: TNF-𝛼 inhibitors have proven suc-
cessful in inducing and maintaining remission of moderate-
to-severe IBD. In addition, CXCL1 is a chemoattractant for
neutrophils and plays a role in inflammation; increased ileal
and colonic CXCL1 gene expression was also reported in IBD
patients [6].
IBD is associated with enhanced production of reactive
metabolites of oxygen and nitrogen (RONS). Moreover,
oxidative stress plays an important role in the pathogen-
esis of this disease [7]. Heme oxygenase-1 (HO-1), the
inducible isoform of heme oxygenase enzymes, is a stress-
responsive enzyme, which can be induced by oxidative stress,
inflammatory cytokines, and many other molecules. HO-
1 is thought to play an important role in the protection
of tissues from oxidative injuries and inflammation [8–10].
These beneficial effects of HO-1 are mediated in part by the
antioxidant and anti-inflammatory end products of heme
breakdown, namely, CO and bilirubin, which can inhibit
the expression of proinflammatory cytokines, such as TNF-
𝛼 and IL-1𝛽. Several molecules, such as interleukin-10 (IL-
10) function through an HO-1 dependent mechanism [11, 12].
Pharmacological studies suggest a beneficial role for HO-1
in modulating colitis. Upregulation of HO-1 by heme and
cadmium chloride can ameliorate while inhibition of the
enzyme by tin protoporphyrin can aggravate experimental
inflammation in the colon [13]. 5-Aminosalicylic-acid, a
clinically approved anticolitic agent, can exert beneficial
effects in vivo, partially through the induction or activation
of HO-1 [14].
Another enzyme involved in intestinal inflammation and
oxidative stress is nitric oxide synthase [15]. The constitutive
production of NO derived from the constitutive isoforms of
the enzyme, namely, neuronal NOS (nNOS) and endothelial
NOS (eNOS), plays a role in various physiological processes
in the GI mucosa, such as the regulation of microvascular
and epithelial permeability and the maintenance of adequate
perfusion [16]. On the other hand the effects of iNOS-
produced [15]NO can be beneficial or detrimental depending
on the amount, duration, and anatomical site of synthesis
[16, 17]. In experimental colitis the downregulation of nNOS
and the overproduction of NO by iNOS are observed [18].
For example, proinflammatory cytokines, such as TNF-𝛼, can
induceNOproduction and iNOS activity in colonic epithelial
cells [17].
Earlier studies have focusedmainly on the role of exercise
in the treatment of extraintestinal manifestations of IBD [19,
20]. However, the effects of physical exercise on the inflamed
gut are still inconsistent. Therefore, the aims of the present
study were to investigate the effects of recreational physical
exercise (1) on the colonic damage in a TNBS rat model
(damage score, lesion), (2) on the gene expression (TNF-𝛼,
IL-1𝛽, CXCL1, and IL-10) and protein concentration (TNF-𝛼)
of inflammatory mediators in experimental acute colitis, and
(3) on the activity of oxidative/antioxidative enzymes (MPO,
HO, andNOS) in the inflamed colon of rats.We hypothesized
that voluntary exercise prior to TNBS challenge will reduce
colonic damage and oxidative and inflammatory mediator
gene and protein expressions.
2. Materials and Methods
2.1. Animals. Male Wistar rats (180–220 g) were housed in
groups. Food was withdrawn overnight before induction of
colitis; otherwise, the animals had access to food anddrinking
water ad libitum throughout the experiments. The animal
care and research protocols were in accordance with the
guidelines of the University of Szeged.
2.2. Experimental Design. The animals were randomly
divided into four groups: 1: sedentary control (nonrunning
non-colitis-induced, 𝑛 = 13), 2: running control (running
non-colitis-induced, 𝑛 = 18), 3: sedentary TNBS (𝑛 = 14),
and 4: running TNBS groups (𝑛 = 18) (Figure 1). Rats of the
running groups were placed in cages with a running wheel
(Acellabor Ltd., Budapest, Hungary). Before the beginning
of experimental period rats were allowed to accommodate
to the running wheel for a week. The activity of the rats on
the running wheel was monitored by a bicycle computer
attached to each wheel. After 6 weeks of self-administered
physical exercise colitis was induced by 2,4,6-trinitrobenzene
sulphonic acid (TNBS; once 10mg in 0.25mL of 50%
ethanol, w/v). The intracolonic administration of TNBS
was performed with an 8 cm long plastic catheter under
transient ether anaesthesia (the method originally described
by Morris et al. [21]). The control groups did not receive
any treatment. Physical activity was continued following
TNBS treatment. Rats were weighed twice a week until
the induction of colitis and then daily following the TNBS
challenge. 72 hours after the induction of colitis the animals
were sacrificed and the distal 8 cm portion of the colon
was dissected, longitudinally opened, gently rinsed with
ice-cold physiological saline, and photographed (Panasonic
Lumix DMC-TZ6, digital camera) for the determination of
macroscopic colonic inflammatory damage. The colon was
weighed and divided into longitudinal segments to be used
for the following molecular and biochemical analyses.
2.3. Damage Score and Lesion Measurement. The extent
of macroscopically apparent inflammation, ulceration, and
tissue disruption was determined in a randomized manner
from the colour images, using a proprietary computerized
planimetry software, developed in our laboratory (Stat 2 1 1).
The area of macroscopically visible mucosal involvement was
calculated and expressed as the percentage of the total colonic
segment area under study.
The degree of colonic inflammation was scored on a 0–11
scale in a randomized, blinded fashion. The criteria has been
adapted from what has been used previously: 0 = no damage,
1 = focal hyperemia and no ulcers, 2 = ulceration without
hyperemia or bowel wall thickening, 3 = ulceration with
inflammation at 1 site, 4 = more than 2 sites of ulceration and
inflammation, 5 = more than 2 major sites of ulceration and
inflammation or 1 site of ulceration/inflammation extending
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Figure 1: Diagram showing the experimental design.
>1 cm along the length of the colon and 6–11 = the score is
increased by 1 for each additional centimetre of involvement
[14].
2.4. Quantification of TNF-𝛼 Protein with the AlphaLISA
Assay. The rat large intestine was immediately frozen in
liquid nitrogen after dissection. During protein extraction
the tissues were stored on ice. We used 1mL RIPA buffer
(150mMNaCl (Molar Chemicals, Budapest, Hungary),
1% Nonidet P-40 (Sigma-Aldrich), 0.5% Na-deoxycholate
(Sigma-Aldrich), 0.1% sodium dodecyl sulfate (Sigma-
Aldrich), and 50mM Tris-HCl (pH 8.0) (Molar Chemicals))
for protein extraction from 40mg tissue, supplemented
with 20𝜇L NEM (N-ethyl-maleinimide) and 20 𝜇L phenyl-
methane-sulfofluoride (PMSF) protease inhibitors. We
homogenized the tissue samples with Ultra-Turrax T25
(IKA-Labortechnik, Staufen, Germany) tissue homogenizer
on ice for 1min. The homogenates were centrifuged for
10min at 10.000×g at 4∘C and the concentration of the
supernatant was measured with a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington,
USA). All samples were then diluted to a uniform 0.5mg/mL
concentration. Until further analyses samples were stored at
−20∘C (stock samples were stored at −80∘C).
For the quantification of TNF-𝛼, we used the AlphaL-
ISA bead based technique, which was developed and is
supported by Perkin Elmer (Perkin Elmer, Massachusetts,
USA). Alpha Technology is a highly sensitive assay ideal
for the measurement of protein interaction. We used 5 𝜇L
volume from0.5mg/mLprotein solution.Thefinal amount of
AlphaLISA Anti-Analyte Acceptor beads was set at 10𝜇g/mL
concentration, while the final amount of Streptavidin-Donor
beads was set at 40 𝜇g/mL. The final working concentration
of Biotinylated Antibody Anti-Analyte was 1 nM. All incu-
bations were under subdued laboratory lighting (<100 lux).
The samples were measured in 50 𝜇L final volume filled
in 384-well polystyrene plates (Tomtec Plastik, Budapest,
Hungary) with an EnVision-Alpha Reader (PerkinElmer).
2.5. Myeloperoxidase Activity. To measure myeloperoxidase
activity we employed a modification of the method described
by Bradley et al. [22]. The 8 cm longitudinal strips of
the colon were weighed, homogenized (Ultra-Turrax T25
IKA-Labortechnik, 13.500 rev/min, twice for 30 s; 250mg
colon/mL buffer) in ice-cold phosphate buffer (50mM,
pH 6.0), containing 0.5% hexadecyltrimethylammonium-
bromide, freeze-thawed three times, and then centrifuged at
10.000×g for 15min at 4∘C. A 12 𝜇L aliquot of the supernatant
was then mixed with 280𝜇L phosphate buffer (50mM, pH
6.0), containing 0.167mg/mL O-adenosine dihydrochloride
(Sigma-Aldrich), and the reaction was started with 10𝜇L
0.03% hydrogen peroxide and assayed spectrophotometri-
cally at 490 nm after 90 sec shaking (Benchmark Microplate
Reader, Bio-Rad Labs, Hercules, CA). MPO activity was
expressed as mU/mg protein.
2.6. Heme Oxygenase Activity. Heme oxygenase activity
was assessed by measuring bilirubin formation with slight
modifications form what has been described by Tenhunen
et al. [23]. The segment of the colon was homogenized
(Ultra-Turrax T25; 13.500/s; twice for 30 sec) in ice-cold
10mM N-[2-hydroxyethyl] piperazine-N󸀠-[2-ethanesulfonic
acid] (HEPES, Sigma-Aldrich), 32mM sucrose (Sigma-
Aldrich), 1mM dithiothreitol (DTT, Sigma-Aldrich), 0.1mM
EDTA, 10 𝜇g/mL soybean trypsin inhibitor (Sigma-Aldrich),
10 𝜇g/mL leupeptin (Sigma-Aldrich), and 2 𝜇g/mL aprotinin
(Sigma-Aldrich), at pH 7.4. The supernatant was collected
by centrifugation for 30min at 20.000×g at 4∘C. Incubation
was carried out in the dark at 37∘C for 60min with the
reaction mixture containing the following ingredients in a
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final volume of 1.5mL : 2mM glucose 6-phosphate (Sigma-
Aldrich), 0.14U/mL glucose 6-phosphate dehydrogenase
(Sigma-Aldrich), 15𝜇M heme, 150 𝜇M 𝛽-nicotinamide ade-
nine dinucleotide phosphate (𝛽-NADPH, Sigma-Aldrich),
120𝜇g/mL rat liver cytosol as a source of biliverdin reductase,
2mM MgCl
2
, 100mM potassium phosphate buffer, and
150 𝜇L of supernatant. The reaction was stopped by placing
the samples on ice.The bilirubin formed was calculated from
the difference between optical densities obtained at 460 and
530 nm. One unit of heme oxygenase activity was defined as
the amount of bilirubin (nmol) produced/hour/mg protein.
2.7. Nitric Oxide Synthase Activity. Nitric oxide synthase
activity was determined by quantifying the conversion of
[14C]-radiolabelled L-arginine to citrulline by a previously
described method with some minor modifications [24].
A segment of colon was homogenized as described for
HO activity. Homogenates were centrifuged for 30min at
20.000×g at 4∘C. Samples (40 𝜇L) were incubated for 10min
at 37∘C in 100 𝜇L of assay buffer (50mM KH
2
PO
4
, 1.0mM
MgCl
2
, 50mML-valine, 0.2mMCaCl
2
, 1.0mMDTT, 1.0mM
L-citrulline, 15.5 nM L-arginine, 30 𝜇M flavin adenine din-
ucleotide, 30 𝜇M flavin mononucleotide, 30𝜇M tetrahydro-
L-biopterin dihydrochloride, 450𝜇M 𝛽-NADPH, and 12 pM
of [14C]-L-arginine monohydrochloride (all from Sigma-
Aldrich)). The reaction was terminated by the addition of
0.5mL of 1 : 1 (v/v) suspension of ice-cold DOWEX (Na+-
form) in distilled water. The mixture was resuspended
with the addition of 850 𝜇L of ice-cold distilled water. The
supernatant (970 𝜇L) was removed and radioactivity was
determined by scintillation counting. Calcium-dependency
of the NOS activity was determined by the addition of 10 𝜇L
of ethylene glycol-bis (𝛽-aminoethyl ether) tetraacetic acid
(EGTA; 1mM, Sigma-Aldrich). NOS activity was confirmed
by inhibition with 10 𝜇L of N𝜔-nitro-L-arginine-methylester
(LNNA; 3.7mM, Sigma-Aldrich). InducibleNOSwas defined
as the citrulline formation that was inhibited by LNNA, but
not by EGTA. The constitutive NOS activity was calculated
from the difference between citrulline formation that was
inhibited by EGTA and the total activity. As the nature of
the constitutive isoform (eNOS or nNOS) was not deter-
mined, this activity is referred to as cNOS. NOS activity was
expressed as pmol/min/mg protein.
2.8. Protein Determination for HO, NOS, and MPO Activity.
Using a commercial protein assay kit (Bio-Rad Labs), aliquots
(20𝜇L) of the diluted samples (15× or 25× with distilled
water) were mixed with 980𝜇L of distilled water with 200𝜇L
Bradford reagent added to each sample. After mixing and
following 10min incubation, the samples were assayed spec-
trophotometrically at 595 nm. Protein level was expressed as
mg protein/mL.
2.9. RNA Extraction, Reverse Transcription, and Quantitative
Reverse Transcriptase Polymerase Chain Reaction (QPCR).
The samples were homogenized in 1mL of TRIzol reagent
(Life Technologies, Carlsbad, CA) with ultra-turrax T-18
basic homogenizer (2×30 sec at 5000 rpm); one-third volume
of chloroform (Sigma-Aldrich) was added to the suspen-
sion with vigorous vortexing. Samples were centrifuged at
13000 rpm for 10 minutes and total RNA was extracted
from the upper phase by using RNeasy Plus Mini Kits
(Qiagen, Germany) according to themanufacturer’s protocol.
In parallel, peripheral bloodmononuclear cells (PBMC) were
isolated from the blood of the same animals by Ficoll Paque
Plus (GE Healthcare, UK) density gradient centrifugation.
Total RNA from PBMCwas also extracted using RNeasy Plus
Mini Kits (Qiagen).The quality and quantity of isolated RNA
were determined using NanoDrop and Bioanalyzer (Agilent,
Santa Clara, USA) measurements.
cDNA was synthesized from 100 ng of total RNA by
using High Capacity RNA to cDNA Kit or SuperScript
Vilo cDNA Synthesis Kit (both from Life Technologies)
according to the manufacturer’s instructions. cDNA levels
were determined by QPCR using StepOne Plus Real-Time
PCR System (Life Technologies). Reactions were performed
with Power SybrGreen Master Mix (Life Technologies) with
the following primer sets:
TNF-𝛼 sense: GCTCCCTCTCATCAGTTCCA,
TNF-𝛼 antisense: GGCTTGTCACTCGAGTTT-
TGA;
CXCL1 sense: CATTAATATTTAACGATGTGGAT-
GCGTTTCA,
CXCL1 antisense: GCCTACCATCTTTAAACT-
GCACAAT [25];
IL-1𝛽 sense: CAGGAAGGCAGTGTCACTCA,
IL-1𝛽 antisense: AGACAGCACGAGGCATTTTT;
IL-10 sense: CCTGCTCCTACTGGCTGGAG,
IL-10 antisense: TTGTTCAGCTGGTCCTTCTT.
To avoid false-positive results due to amplification of con-
taminating genomic DNA in the cDNA preparation, we used
primers spanning exon-exon junctions. All measurements
were performed in duplicates with at least four biological
replicates. The ratio of each mRNA relative to the 18S rRNA
(assay ID: Hs99999901; Life Technologies) was calculated
using the ΔΔ𝐶
𝑇
method.
2.10. Data Representation and Statistical Analysis. Results
of the body weight change, damage score, lesion, and the
activity of MPO, HO, cNOS, and iNOS are shown as mean
± S.E.M; statistical comparisons were performed by two-
tailed Student’s t-test. Statistical analysis of the TNF-𝛼 protein
secretionwas performed using one-wayANOVA.QPCR data
are presented as data points and median; the significance of
the differences between samples was determined by applying
the Newman-Keuls test using GraphPad Prism forWindows.
In all statistical comparisons, a probability (𝑃) value of less
than 0.05 was considered significant.
3. Results
3.1. Alteration of Body Weight after Running and TNBS
Treatment. Running distance averaged 2600 meters/day/rat.
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Figure 2: Body weight changes during the 6 weeks of running (a) and after the TNBS treatment (b). Results are shown as mean ± S.E.M.
(∗𝑃 < 0.05 compared to the sedentary nontreated control group, 𝑛 = 34–43).
We did not find any differences between the body weights
of sedentary and running groups during the 6 weeks of
exercise before TNBS administration (Figure 2(a)). On the
other hand, there was a progressive decrease in body weight
after the induction of colonic inflammation in the TNBS
treated groups (Figure 2(b)).
3.2. Effects of 6-Week Running and TNBS Challenge on
Damage Score, Mucosal Lesions, and MPO Activity. The
severity of mucosal damage was scored on a 0–11 scale by a
randomized, blinded fashion. 6 weeks of running before the
TNBS challenge significantly (𝑃 < 0.001) decreased the level
of this inflammatory damage score marker from 7.6 ± 0.3 to
6.6 ± 0.3 (Figure 3(a)).
Challenge with TNBS caused hemorrhagic and necrotic
damage of the colonic mucosa, as determined macroscopi-
cally 72 hours after TNBS administration. In the sedentary,
nonrunning group the level of damage reached 54.6 ± 2.63%
of the total colonic area. We detected a significant decrease
(42.9 ± 3.21%, 𝑃 < 0.01) in macroscopic injury in the colons
of the trained, TNBS-treated group (Figures 3(b) and 3(c)).
Following treatment with TNBS, there was a thirtyfold
increase in colonic MPO activity, suggesting massive neu-
trophil infiltration [22]. Wheel running significantly (𝑃 <
0.01) attenuated the elevation of MPO activity from 880.6 ±
79.3 to 568.4 ± 59.9mU/mg protein (Figure 4).
3.3. The Effect of Physical Exercise on the Gene Expression
Profiles of Selected Pro- and Anti-Inflammatory Mediators in
TNBS-Induced Experimental Acute Colitis. In PBMCs, the
physical exercise alone significantly (𝑃 < 0.05) downreg-
ulated the gene expression of IL-1𝛽, CXCL1 and IL-10 as
compared to the inactive group (Figure 5(a)). TNBS treat-
ment alone only downregulated the expression of CXCL1,
and had no effect on the expression of TNF-𝛼, IL-1𝛽, and IL-
10 transcripts. Interestingly, exercise before TNBS treatment
downregulated the expression of CXCL1 and IL-10. Notably,
the downregulation of IL-10 was significant as compared to
not only absolute controls but also to TNBS treatment alone
(Figure 5(a)).
In contrast to the downregulated expression pattern
detected in PBMCs, physical exercise alone did not alter
the gene expression of the monitored inflammatory medi-
ators in the colon when compared to sedentary controls
(Figure 5(b)). Yet, TNBS treatment alone induced marked
upregulation (𝑃 < 0.05) in the expression of pro- but not
anti-inflammatorymediators (IL-1𝛽, CXCL1, and IL-10, resp.)
in the colon. Furthermore, exercise significantly attenuated
TNBS-induced upregulation of proinflammatory mediators
(IL-1𝛽, CXCL1) and significantly increased expression of anti-
inflammatory IL-10 (Figure 5(b)).
3.4. Effect of Running and/or TNBS Challenge on Colonic
TNF-𝛼 Protein Content. 6-week running had no significant
effect on the colonic content of TNF-𝛼. In the inflamed
colons we found a doubling of TNF-𝛼 concentration in the
sedentary group (578.4±118.47 pg/mL), and although 6-week
running before TNBS treatment slightly decreased TNF-𝛼
levels (496.16±87.77 pg/mL), the decrease was not significant
compared to the sedentary TNBS group (Figure 6(a)).
3.5. Changes in Colonic HO Activity by Physical Exercise
and/or TNBS Treatment. Voluntary physical exercise sig-
nificantly increased HO activity from 1.3 ± 0.2 to 2.8 ±
0.3 nmol bilirubin/h/mg protein (𝑃 < 0.001). Treatment with
TNBS alone led to even higher HO activity (6.9 ± 0.4 nmol
bilirubin/h/mg protein, 𝑃 < 0.001), after 6 weeks of exercise
slightly increased the HO activity, but this difference was
not significant between the running TNBS group and the
nonrunning TNBS group (Figure 6(b)).
3.6. Effects of TNBS Treatment and/or Physical Exercise on
Colonic cNOS Activity. The 6-week running alone caused
a significant (𝑃 < 0.05) increase in cNOS activity.
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Figure 3: Effects of 6 weeks of running on macroscopic colonic inflammatory damage score (a) and lesion (b) in TNBS-induced colitis after
72 hrs. Results are shown asmean ± S.E.M. (∗∗𝑃 < 0.01 and ∗∗∗𝑃 < 0.001 compared to the sedentary TNBS group, 𝑛 = 13–19). Representative
images of freewheel running and induction of colonic inflammation: sedentary control, and running control, sedentary TNBS, running TNBS
(c).
In the nonrunning TNBS group we have measured a sig-
nificantly decreased (𝑃 < 0.001) cNOS activity (from
321.1 ± 35.16 to 108.9 ± 25.6 pmol/min/mg protein) com-
pared to the nontreated control group. Voluntary exercise
before TNBS administration significantly (𝑃 < 0.001)
augmented cNOS activity from 108.9 ± 25.6 to 333.9 ±
32.3 pmol/min/mg protein compared to the nonrunning
TNBS group (Figure 7(a)).
3.7. Effects of TNBS Treatment and/or Physical Exercise
on Colonic iNOS Activity. Inflammation caused by TNBS
challenge significantly elevated (𝑃 < 0.01) iNOS activity
(from 21.4 ± 5.49 to 217.5 ± 26.43 pmol/min/mg protein)
independently of exercise. Importantly, the 6-week running
before TNBS treatment significantly (𝑃 < 0.05) reduced
this increase of iNOS activity from 217.5 ± 26.43 to 128.9 ±
15.82 pmol/min/mg protein (Figure 7(b)).
4. Discussion
The results of the present study demonstrate that 6-week
physical exercise before TNBS challenge can ameliorate the
severity and extent of colonic damage caused by TNBS
treatment in rats by downregulating the expression of proin-
flammatory mediators, inducing the expression of anti-
inflammatory mediators, and affecting the activity of cNOS
and iNOS enzymes.
In this study we used the 2,4,6-trinitrobenzene-sulfonic-
acid- (TNBS-) induced rat acute colitis model, in which the
inflammatory response is due to the generation of transmural
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Figure 4: MPO activity in rats treated with TNBS after 6 weeks of
resting or 6 weeks of running. Results are shown as mean ± S.E.M.
(∗∗𝑃 < 0.01 compared to the sedentary TNBS group, 𝑛 = 7–16).
oxidative stress and release of proinflammatory mediators
[26, 27]. We used a voluntary wheel running model to mimic
leisure-type physical exercise, which induces lower degree of
stress compared to swimming or treadmill exercise protocols
due to the reduced handling of animals and stress-inducing
exercise motivators [28].
The body weights after 6 weeks of running did not
show any differences compared to the nonrunning groups,
however, body composition was not examined.
Intracolonic administration of TNBS causes an acute,
severe, transmural inflammation, whichmimics several clini-
cal and morphological features of Crohn’s disease [26]. In the
sedentary colitis group on average, 50% of the 8 cm colonic
portion was inflamed with ulceration and we have also found
a 30-fold elevation in MPO activity.
In order to determine if gene expression changes of
PBMCs reflect that of the inflamed colon, we have monitored
the gene expression changes of well-known inflammatory
markers. Interestingly, we found that 6 weeks of running
alone downregulated the expression of both pro- and anti-
inflammatory mediators (IL-1𝛽, CXCL1, and IL-10, resp.)
in PMBCs but not in the colon. In addition, in the colon
physical exercise only attenuated the expression level of anti-
inflammatory IL-10 compared to sedentary TNBS-treated
animals.
In contrast to PBMCs, TNBS induced marked upreg-
ulation of proinflammatory cytokines IL-1𝛽 and CXCL1 in
the colon, which is in good agreement with previous studies
showing elevated expression of these molecules in IBD [6].
Importantly, recreational physical exercise downregulated
TNBS-induced expression of both cytokines. In parallel,
we detected markedly elevated IL-10 expression in running
TNBS animals. These observations, together with those
showing decreased level of damage score in physically active
animals, suggest that physical activity indeed ameliorates
the extent of the inflammation caused by TNBS. However, it
remains to be determined if physical activity shows a similar
protective effect in patients with chronic IBD.
Although there was no change in TNF-𝛼 gene expression
we found a significantly increased TNF-𝛼 protein content in
the inflamed colon with TNBS in accordance with earlier
findings [26, 29]. We hypothesize that polymorphism in
TNF-𝛼 promoter regions could be responsible for discrepan-
cies between gene and protein expression level [30]. However,
no significant decrease in TNF-𝛼 protein content was seen
after exercise in the TNBS-treated group compared to the
nonrunning TNBS-treated group. It is feasible that exercise
impacts inflammation through pathways other than TNF-𝛼,
because several other markers were attenuated in our study,
indicating the effectiveness of this intervention against IBD.
The elevated HO activity suggests the involvement of
oxidative stress in colonic damage. Earlier findings demon-
strated the ability of chemically induced HO to reduce the
extent and intensity of experimental colonic inflammation
[14]. Several studies demonstrated that long-lasting exercise
can induce antioxidant mechanisms in a variety of tissues,
probably as a defensive response to oxidative stress [31].
Brooks et al. [32] demonstrated that 8 weeks of treadmill
running reduced the release of ROS andNO from contracting
muscles and increased skeletal muscle antioxidant content
such as glutathione and protein thiols in mice. George et al.
[33] found an elevated activity and expression of superoxide
dismutase and HO-1 in the plasma and renal proximal
tubules of rats after treadmill training for 12 weeks. Our
observations that a 6-week voluntary exercise can induce
colonic HO activity also agree with previous data, supporting
the antioxidant effects of moderate training. Along these
lines, Kasimay et al. demonstrated the protective role of 6
weeks of wheel running against oxidative colonic injury in a
model of acetic acidinduced intestinal inflammation [34].
We found opposite changes of cNOS and iNOS activity in
the inflamed colon. Our observations of decreased cNOS and
increased iNOS activity in the sedentary colitis group are also
consistent with previous findings. We do not know to what
extent the two constitutive isoforms (nNOS and eNOS) are
responsible for the reduction of cNOS activity. Experiments
with eNOS deficient mice show the important role of the
other constitutive NOS isoform in limiting intestinal injury
in IBD [35]. In IBD nNOS is downregulated, while iNOS
expression increases cyclically during the active phase of
inflammation. Excess NO produced by iNOS can generate
the prooxidant peroxynitrite [36]. This overproduction of
NO by upregulation of iNOS seems to be responsible for the
observed intestinal hypomotility and subsequent bacterial
overgrowth [18].
We presented that rat colonic cNOS activity increased,
while iNOS activity remained unchanged with exercise com-
pared to the sedentary control group. Together with the
observed expression changes induced by TNBS, it appears
that prior exercise is able to mitigate colonic inflamma-
tion and macroscopic damage by maintaining cNOS and
attenuating iNOS expression in IBD. These observations are
also in agreement with previous data, showing that regular
physical activity induces increased eNOSgene expression and
8 Oxidative Medicine and Cellular Longevity
IL-1𝛽TNF-𝛼 CXCL1 IL-10
0.06250.06250.06250.0625Re
lat
iv
e g
en
e e
xp
re
ss
io
n
PB
M
Cs
8
4
2
1
0.5
0.25
0.125
4
2
1
0.5
0.25
0.125
4
2
1
0.5
0.25
0.125
2
1
0.5
0.25
0.125
∗
∗∗
∗∗
∗
∗
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
fo
ld
 ch
an
ge
 (L
og
2
)
(a)
0.0625
2
64
0.125
0.25
0.5
1
4
8
16
32
0.0625
2
64
0.125
0.25
0.5
1
4
8
16
32
0.0625
2
64
0.125
0.25
0.5
1
4
8
16
32
Re
lat
iv
e g
en
e e
xp
re
ss
io
n
C
ol
on
0.0625
8
4
2
1
0.5
0.25
0.125
∗∗
∗∗
∗
∗
∗ ∗
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
Ru
nn
in
g 
co
nt
ro
l
Se
de
nt
ar
y 
TN
BS
Ru
nn
in
g 
TN
BS
fo
ld
 ch
an
ge
 (L
og
2
)
(b)
Figure 5: The relative gene expression of selected pro- and anti-inflammatory mediators in peripheral blood mononuclear cell (PBMC) (a)
and colon (b).The expression pattern of TNF-𝛼, IL-1𝛽, CXCL1, and IL-10 from sedentary and running groupswith or without TNBS treatment
was determined with qPCR and compared to sedentary nontreated animals (absolute controls). Results are shown as data points and median
(∗𝑃 < 0.05; 𝑛 = 6–20).
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Figure 6: (a) Concentration of TNF-𝛼 in 1 g tissue in sedentary and running groups with or without TNBS treatment. Results are shown as
mean ± S.D. (+𝑃 < 0.05; 𝑛 = 4–10). (b) Effects of 6 weeks of running on colonic HO activity either in the control group or in TNBS-induced
colitis after 72 hrs. Results are shown as mean ± S.E.M. (+++𝑃 < 0.001 compared to the sedentary nontreated control group, 𝑛 = 8–16).
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Figure 7: Effects of 6 weeks of running on colonic cNOS activity (a) and iNOS activity (b) either in the control group or in TNBS-induced
colitis after 72 hrs. Results are shown as mean ± S.E.M. (+𝑃 < 0.05, ++𝑃 < 0.01, and +++𝑃 < 0.001 compared to the sedentary control group
and ∗𝑃 < 0.05, ∗∗∗𝑃 < 0.001 compared to the sedentary TNBS group, 𝑛 = 6–15).
reduces the expression of iNOS in CD34(+) PBMCs [37].
Moreover, NO-releasing derivative of aspirin can accelerate
the healing of colonic inflammation in an animal model
[38]. Our results are in agreement with earlier studies
about naturally occurring compounds and drugs such as
naringenin, a flavonoid in citrus, grapefruits, and tomatoes
[39] 3,4-oxo-isopropylidene-shikimic acid [40] which has
anti-inflammatory effect on experimental colitis through
reduction of the expression of inflammatory cytokines and
mediators such as iNOS. Therefore, it appears that the NO
pathway plays a central role in the resolution of inflammation
in IBD.
Exercise has been speculated to be protective against the
onset of IBD, but the literature is inconsistent. Preliminary
studies reveal that exercise training (relatively low intensity)
may be beneficial to reduce stress and symptoms of IBD. Cur-
rent research also recommends exercise to help counteract
some IBD-specific complications by improving bone min-
eral density, immunological response, psychological health,
weight loss, and stress management ability. However, the
literature advises that some patients with IBD may have
limitations to the amount and intensity of exercise that they
can perform [2].
It has become clear that physical activity is not harmful
for patients with inflammatory bowel disease, despite acute
exercise related responses, such as increased serum mal-
ondialdehyde levels and activated neutrophils. In addition,
physical activity may reduce disease activity and improve
physical health, general well-being, and perceived stress. In
summary, exercise may be beneficial to IBD patients, but
further research is required to make a convincing conclusion
regarding its role in the management of IBD and to help
establish exercise regimens that can account for each IBD
patient’s unique presentation [2]. In conclusion, in the present
study we aimed to investigate young adult rats, which are
age-matched population to the incidence of IBD [41]. Our
results suggest that exercise may be protective against the
onset of IBD through the modulation of pro- and anti-
inflammatory and antioxidant mediators with HO and NOS
enzymes playing a central role in these effects. Along these
lines, regular exercise can promote healthy aging via the same
mechanisms.
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